Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P1.01-40 Randomized Phase II Study of Docetaxel Plus Bevacizumab or Pemetrexed Plus Bevacizumab for Elderly PTS With Untreated Advanced NSCLC: TORG1323

Journal of Thoracic Oncology

English

Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P2.13-38 Impact of Tyrosine Kinase Inhibitor (TKI) Dose on Outcomes of Patients With Lung Cancer

Journal of Thoracic Oncology

English

MA09.05 Can We Predict Radiosensitivity in Non-Small Cell Lung Cancer?

Journal of Thoracic Oncology

English

MTE08.01 Enhancing the Nurse's Role in Tobacco Prevention and Cessation: New Challenges

Journal of Thoracic Oncology

English

P2.01-97 Prognostic Factors in Resected Lung Mucinous Adenocarcinoma: Clinical and Pathological Features

Journal of Thoracic Oncology

English

P2.09-19 Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment

Journal of Thoracic Oncology

English

OA10.01 Patient Preferences for Tyrosine Kinase Inhibitor Treatments for EGFR Mutation Positive Metastatic NSCLC

Journal of Thoracic Oncology

English

P2.01-25 MicroRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer by Activating MAPK/MEK/ERK Signaling Through GRIA3

Journal of Thoracic Oncology

English

P3.11-23 Adherence to Annual Low-Dose CT Lung Cancer Screening at a Large Academic Institution

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P1.01-40 Randomized Phase II Study of Docetaxel Plus Bevacizumab or Pemetrexed Plus Bevacizumab for Elderly PTS With Untreated Advanced NSCLC: TORG1323

Co-Expression Analysis Reveals Mechanisms Underlying the Varied Roles of NOTCH1 in Non-Small Cell Lung Cancer

P2.13-38 Impact of Tyrosine Kinase Inhibitor (TKI) Dose on Outcomes of Patients With Lung Cancer

MA09.05 Can We Predict Radiosensitivity in Non-Small Cell Lung Cancer?

MTE08.01 Enhancing the Nurse's Role in Tobacco Prevention and Cessation: New Challenges

P2.01-97 Prognostic Factors in Resected Lung Mucinous Adenocarcinoma: Clinical and Pathological Features

P2.09-19 Utilising Heterogeneity: Using a Digital Database of Lung Cancers and Immune Profile to Complement Subjective Assessment

OA10.01 Patient Preferences for Tyrosine Kinase Inhibitor Treatments for EGFR Mutation Positive Metastatic NSCLC

P2.01-25 MicroRNA-330-3p Promotes Brain Metastasis of Non-Small Cell Lung Cancer by Activating MAPK/MEK/ERK Signaling Through GRIA3

P3.11-23 Adherence to Annual Low-Dose CT Lung Cancer Screening at a Large Academic Institution